Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation

被引:9
作者
Ge, Pan [1 ]
Ross, Ted M. [1 ,2 ]
机构
[1] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA
[2] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA
关键词
Glycosylation; HA; influenza; mutation; N-LINKED GLYCOSYLATION; HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; RECEPTOR-BINDING SPECIFICITY; AMINO-ACID SUBSTITUTIONS; A VIRUS; GENETIC-CHARACTERIZATION; H1N1; RECOGNITION; ACTIVATION; VIRULENCE;
D O I
10.1080/14760584.2021.1908135
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: As the pathogen that caused the first influenza virus pandemic in this century, the swine-origin A(H1N1) pdm09 influenza virus has caused continuous harm to human public health. The evolution of hemagglutinin protein glycosylation sites, including the increase in number and positional changes, is an important way for influenza viruses to escape host immune pressure. Based on the traditional influenza virus molecular monitoring, special attention should be paid to the influence of glycosylation evolution on the biological characteristics of virus antigenicity, transmission and pathogenicity. The epidemiological significance of glycosylation mutants should be analyzed as a predictive tool for early warning of new outbreaks and pandemics, as well as the design of vaccines and drug targets. Areas covered: We review on the evolutionary characteristics of glycosylation on the HA protein of the A(H1N1)pdm09 influenza virus in the last ten years. Expert opinion: We discuss the crucial impact of evolutionary glycosylation on the biological characteristics of the virus and the host immune responses, summarize studies revealing different roles of glycosylation play during host adaptation. Although these studies show the significance of glycosylation evolution in host-virus interaction, much remains to be discovered about the mechanism.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 101 条
[1]   Impact of glycoscience in fighting Covid-19 [J].
Adamo, Roberto ;
Sonnino, Sandro .
GLYCOCONJUGATE JOURNAL, 2020, 37 (04) :511-512
[2]   Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017 [J].
Al Khatib, Hebah A. ;
Al Thani, Asmaa A. ;
Yassine, Hadi M. .
ARCHIVES OF VIROLOGY, 2018, 163 (11) :3035-3049
[3]  
Alberts B., 2002, Studying Gene Expression and Function, Vfourth
[4]   Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs [J].
Alymova, IV ;
Kodihalli, S ;
Govorkova, EA ;
Fanget, B ;
Gerdil, C ;
Webster, RG .
JOURNAL OF VIROLOGY, 1998, 72 (05) :4472-4477
[5]   N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing [J].
An, Yanming ;
Parsons, Lisa M. ;
Jankowska, Ewa ;
Melnyk, Darya ;
Joshi, Manju ;
Cipollo, John F. .
JOURNAL OF VIROLOGY, 2019, 93 (02)
[6]   Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms [J].
An, Yanming ;
Rininger, Joseph A. ;
Jarvis, Donald L. ;
Jing, Xianghong ;
Ye, Zhiping ;
Aumiller, Jared J. ;
Eichelberger, Maryna ;
Cipollo, John F. .
JOURNAL OF PROTEOME RESEARCH, 2013, 12 (08) :3707-3720
[7]  
[Anonymous], 2016, REC COMP INFL VIR VA
[8]   SINGLE AMINO-ACID SUBSTITUTIONS IN THE HEMAGGLUTININ CAN ALTER THE HOST RANGE AND RECEPTOR-BINDING PROPERTIES OF H1-STRAINS OF INFLUENZA-A VIRUS [J].
AYTAY, S ;
SCHULZE, IT .
JOURNAL OF VIROLOGY, 1991, 65 (06) :3022-3028
[9]   STRUCTURE OF INFLUENZA HEMAGGLUTININ AT THE PH OF MEMBRANE-FUSION [J].
BULLOUGH, PA ;
HUGHSON, FM ;
SKEHEL, JJ ;
WILEY, DC .
NATURE, 1994, 371 (6492) :37-43
[10]  
Centers for Disease Control and Prevention, 2010, 2009 H1N1 FLU INT SI